RVMD - Revolution Medicines, Inc. -  [ ]

Ticker Details
Revolution Medicines, Inc.
IPO Date: February 13, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $19.69B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.86 | 2.63%
Avg Daily Range (30 D): $1.51 | 1.44%
Avg Daily Range (90 D): $1.56 | 1.93%
Institutional Daily Volume
Avg Daily Volume: .97M
Avg Daily Volume (30 D): 3M
Avg Daily Volume (90 D): 2.51M
Trade Size
Avg Trade Size (Sh.): 70
Avg Trade Size (Sh.) (30 D): 69
Avg Trade Size (Sh.) (90 D): 67
Institutional Trades
Total Institutional Trades: 5,589
Avg Institutional Trade: $3.57M
Avg Institutional Trade (30 D): $6.66M
Avg Institutional Trade (90 D): $5.77M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $7.5M
Avg Closing Trade (30 D): $37.97M
Avg Closing Trade (90 D): $29.36M
Avg Closing Volume: 192.02K
 
News
Jan 29, 2026 @ 1:00 PM
Breakthru Medicine emerges from stealth with $60M ...
Source: Not Specified
Jan 27, 2026 @ 12:16 AM
Why Revolution Medicines Stock Plummeted by Almost...
Source: Eric Volkman
Jan 26, 2026 @ 6:26 PM
Natural Gas Rallies 30%, Silver Jumps 13% To $116:...
Source: Piero Cingari
Jan 26, 2026 @ 12:52 PM
Why Is Cancer Drug Developer Erasca Stock Trading ...
Source: Vandana Singh
Jan 26, 2026 @ 11:01 AM
Revolution Medicines Stock Sinks After Merck Deal ...
Source: Vandana Singh
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-5.19 $-1.61 $-1.31
Diluted EPS $-5.19 $-1.61 $-1.31
Revenue $M $M $M
Gross Profit
Net Income / Loss $-960.98M $-305.21M $-247.79M
Operating Income / Loss $-1037.05M $-315.27M $-264.71M
Cost of Revenue
Net Cash Flow $18.15M $-184.05M $69.1M
PE Ratio